Home
About
Overview
Sharing Data
ORCID
Help
History (10)
Genetic and pharmacological evidence for a novel, intermediate phase of long-term potentiation suppressed by calcineurin.
Ostrowski, Simon
Lincoln, Thomas
Psychiatric Presentations and Medication Use in Older Adults With Intellectual and Developmental Disabilities.
Targeting Lipooligosaccharide (LOS) for a Gonococcal Vaccine.
See All 10 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Targeting Lipooligosaccharide (LOS) for a Gonococcal Vaccine.
Gulati S, Shaughnessy J, Ram S, Rice PA. Targeting Lipooligosaccharide (LOS) for a Gonococcal Vaccine. Front Immunol. 2019; 10:321.
View in:
PubMed
subject areas
Animals
Bacterial Vaccines
Complement System Proteins
Epitopes
Gonorrhea
Humans
Lipopolysaccharides
Neisseria gonorrhoeae
Peptides
authors with profiles
Peter A Rice MD
Sanjay Ram MD
Jutamas Shaughnessy MD, PhD